Alt tag

Adviser’s Picks 2021

When should dual pathway inhibition be stopped in patients with symptomatic PAD following peripheral revascularization?

When should dual pathway inhibition be stopped in patients with symptomatic PAD following peripheral revascularization?

When should dual pathway inhibition be stopped in patients with symptomatic PAD following peripheral revascularization?

Antithrombotic protection after lower-extremity revascularization: Can clopidogrel be used alongside DPI?

Antithrombotic protection after lower-extremity revascularization: Can clopidogrel be used alongside DPI?

Antithrombotic protection after lower-extremity revascularization: Can clopidogrel be used alongside DPI?

Never miss out on the latest news!

Sign up to the Thrombosis Adviser newsletter.